Actinium Pharmaceuticals (ATNM) Non-Current Deffered Revenue (2022 - 2026)
Actinium Pharmaceuticals' Non-Current Deffered Revenue came in at $35 million for Q1 2026, unchanged from $35 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Actinium Pharmaceuticals (ATNM) Non-Current Deffered Revenue (2022 - 2026) Analysis & Trends
Going back to Q4 2022, Actinium Pharmaceuticals' Non-Current Deffered Revenue data covers 13 quarters.
- Non-Current Deffered Revenue carries a three-year compound annual growth rate of 0.0% (FY2022 to FY2025).
- Going back by year, Non-Current Deffered Revenue was $35 million in FY2024 (unchanged), $35 million in FY2023 (unchanged) and $35 million in FY2022.
- Business Quant data shows ATNM's Non-Current Deffered Revenue at $35 million (Q4 2025), $35 million (Q3 2025) and $35 million (Q2 2025) in the three quarters before Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | - |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Actinium Pharmaceuticals | 36.16 Mn | 36.16 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 35.00 Mn |
| Dec 31, 2025 | 35.00 Mn |
| Sep 30, 2025 | 35.00 Mn |
| Jun 30, 2025 | 35.00 Mn |
| Mar 31, 2025 | 35.00 Mn |
| Dec 31, 2024 | 35.00 Mn |
| Sep 30, 2024 | 35.00 Mn |
| Jun 30, 2024 | 35.00 Mn |
| Mar 31, 2024 | 35.00 Mn |
| Dec 31, 2023 | 35.00 Mn |
| Sep 30, 2023 | 35.00 Mn |
| Mar 31, 2023 | 35.00 Mn |
| Dec 31, 2022 | 35.00 Mn |
API Access
Actinium Pharmaceuticals Non-Current Deffered Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=ATNM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deffered-revenue", "ticker": "ATNM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=ATNM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();